Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Celgene Corporation (CELG) A Good Stock To Buy?

Page 1 of 2

Is Celgene Corporation (NASDAQ:CELG) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. The top picks of these firms have historically outperformed the market when we account for known risk factors, making them very valuable investment ideas.

Is Celgene Corporation (NASDAQ:CELG) a cheap investment today? The smart money is betting on the stock. The number of long hedge fund positions advanced by 4 in recent months. Celgene Corporation (NASDAQ:CELG) was in 62 hedge funds’ portfolios at the end of the third quarter of 2015. There were 58 hedge funds in our database with Celgene Corporation (NASDAQ:CELG) holdings at the end of the previous quarter. At the end of this article, we will also compare Celgene Corporation (NASDAQ:CELG) to other stocks, including Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU), QUALCOMM, Inc. (NASDAQ:QCOM), and Starbucks Corporation (NASDAQ:SBUX) to get a better sense of its popularity.

Follow Celgene Corp (NASDAQ:CELG)
Trade (NASDAQ:CELG) Now!

At the moment, there are many methods shareholders use to assess publicly traded companies. A pair of the most underrated methods are hedge fund and insider trading activity. Our experts have shown that, historically, those who follow the top picks of the top hedge fund managers can trounce the market by a significant amount (see the details here).

With all of this in mind, we’re going to view the latest action regarding Celgene Corporation (NASDAQ:CELG).

What does the smart money think about Celgene Corporation (NASDAQ:CELG)?

At the end of Q3, a total of 62 of the hedge funds tracked by Insider Monkey were bullish on this stock, an increase of 7% from one quarter earlier. With hedge funds’ sentiment swirling, there exists a few noteworthy hedge fund managers who were increasing their holdings substantially (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Samuel Isaly’s OrbiMed Advisors has the largest position in Celgene Corporation (NASDAQ:CELG), worth close to $388.7 million, corresponding to 3.9% of its total 13F portfolio. Coming in second is Alkeon Capital Management, managed by Panayotis Takis Sparaggis, which holds a $209.3 million position; the fund has 4.4% of its 13F portfolio invested in the stock. Some other peers that hold long positions consist of Cliff Asness’ AQR Capital Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, and Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!